Codexis Bio (CDXS): Earnings per share for the last twelve months
Codexis, Inc. (CDXS) is recognized as the gold standard in biocatalysis, having earned the full trust of the largest pharmaceutical behemoths. The profit per unit trend over the last 12 months reflects market dynamics where -0.34 determines the current value of the metric. Growth is driven by the CodeEvolver platform for creating unique proteins, while cost optimization is achieved through the use of certified contract manufacturing while maintaining the R&D center in California.
Financial and market metric breakdowns for Codexis Inc (CDXS)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
- earnings and valuation multiples indicators:
CDXS - Company Profit|Future Profit Codexis, Inc.|CDXS - Price to Earnings Multiple|Future Price to Earnings Codexis Bio|CDXS - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Codexis|CDXS - Operating profit before amortization|Earnings per share for the last twelve months Codexis, Inc.|CDXS - Earnings per share for the last 12 months|Quarterly EPS earnings growth codexis.com|CDXS - Earnings growth in current year|Earnings growth forecast for next year Codexis, Inc.
Initial company analysis:codexis.com - CDXS
The development of biocatalysts within a secure US perimeter provides Codexis, Inc. (CDXS) with stability, as reflected in the trailing twelve-month (TTM) net income per share. This indicator is calculated by dividing the total annual profit by the number of shares, allowing investors to assess the real efficiency of the business regardless of issuance factors and determine the fair market value of the security.
Competitors of Codexis, Inc.
Tempus AI - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters qiagen.com QGEN|Ionis (IONS) - Earnings per share for the last twelve months|RGEN - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months RNA|CRSP: Earnings per share for the trailing year|Net earnings per share (EPS TTM) WGS|Net earnings per share for the last four quarters ultragenyx.com|Earnings per share for the last twelve months Beam Therapeutics BEAM|SRPT: Earnings per share for the last 12 months|Twist Bio - Net earnings per share (EPS TTM)|10x (TXG) - Net earnings per share for the last 12 months|NTLA (Intellia Therapeutics) - Net earnings per share for the last 12 months|STOK - Net earnings per share for the last four quarters|BLFS (BioLife Solutions) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Wave Life Sciences Ltd (WVE)|Net earnings per share (EPS TTM) MAZE|Sionna Corp - Earnings per share for the last 12 months|Prime Medicine, Inc. - Net earnings per share for the last 12 months|TSHA: Earnings per share for the last 12 months|QURE - Earnings per share for the last twelve months|Net earnings per share for the last four quarters MeiraGTx Holdings MGTX|RGNX: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLDB|Earnings per share for the last twelve months Ocugen, Inc.|Earnings per share for the last 12 months PACB (pacb.com)|Net earnings per share (EPS TTM) BNTC|Net earnings per share (EPS TTM) Design Therapeutics Inc (DSGN)|Net earnings per share (EPS TTM) RCKT (Rocket Pharmaceuticals Inc)|FDMT - Net earnings per share for the last 12 months|LXEO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Korro Bio, Inc.|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|PRQR (ProQR) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Sangamo BioSciences SGMO|Net earnings per share for the last 12 months NAUT (Nautilus Biotechnology)|metagenomi.co - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) DTIL (Precision BioSciences, Inc.)|Net earnings per share for the last four quarters Generation Bio Co (GBIO)|BOLD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Exicure, Inc. XCUR|IMNN (imunon.com) - Net earnings per share for the last 12 months|Phio Pharmaceuticals Corp. - Earnings per share for the trailing year|MBIO (Mustang Bio Inc) - Net earnings per share (EPS TTM)|TransCode (RNAZ) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Bionano Genomics, Inc. (BNGO)|Applied DNA Corp - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio, Inc.)|IPA - Net earnings per share for the last 12 months|OMGA: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Singular Genomics Systems, Inc. OMIC|RGLS: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Syros Pharmaceuticals, Inc|TBIO (Telesis Bio, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TCON (traconpharma.com)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)
